Subscribe

Medley, Inc. (4480.T)

JPY2,102.00 +27.00 (+1.30%)
JP JPX Healthcare Medical - Healthcare Information Services
Address Sumitomo Fudosan Roppongi Grand Tower 106-6222
Tokyo, JP
CEO Kohei Takiguchi
Website medley.jp
IPO 2019-12-12
ISIN JP3921310003

Explore sections of this company profile

Description

Medley, Inc., a company based in Japan, develops and manages digital platforms for both the recruitment and medical industries. Its operations are structured into three primary segments: HR Platform Business, Medical Platform Business, and New Services. The firm's portfolio of offerings includes JobMedley, a human resources recruitment system specifically for medical, healthcare, and related sectors; CLINICS Telemedicine, a system enabling virtual consultations between patients and healthcare providers; CLINICS, a cloud-based platform for medical facility support; Pharms, which provides support systems for pharmacy front-desk operations; MEDLEY, a service offering medical information to patients; and Kaigo-no Honne, an online portal for searching nursing care facilities. Additionally, Medley, Inc. undertakes proof-of-concept testing for its Pharms solutions. The company was established in 2009 and maintains its corporate headquarters in Tokyo, Japan.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
JPY2,102.00 +27.00 (+1.30%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
228.8K
Beta
0.75
Float Shares
19.59M
Free Float %
63.4%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-5.58% -10.88% -11.72% +3.80% -19.84% -12.48% -36.00% -56.93% -47.15% +63.19% +63.19%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
2,102.00
DCF (Unlevered) 7,432.30 +253.6%
DCF (Levered) 6,869.99 +226.8%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 80% Bullish
Rating 2026-05 Change
Strong Buy 2 0
Buy 2 0
Hold 1 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
2.70
Grey zone
Piotroski F-Score
5 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
B-
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Healthcare Information Services: +14.2%
    +25.5% ★ Q1'26: +25.2% (vs Q1'25)
  • ✗
    EPS growth Medical - Healthcare Information Services: +43.1%
    -64.4% Q1'26: +12.1% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Healthcare Information Services: +49.2%
    +8.2% ★ Q1'26: +0.0% (vs Q1'25)
  • ✗
    EBIT margin Medical - Healthcare Information Services: +8.8%
    +5.8% Q1'26: -0.7% (vs Q1'25)
  • ✗
    ROIC Medical - Healthcare Information Services: +5.2%
    +5.8% ★ Q1'26: -0.7% (vs Q1'25)
  • ✓
    Share dilution Medical - Healthcare Information Services: -0.1%
    -2.1% ★ Q1'26: -6.2% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Healthcare Information Services: -0.74×
    3.49× Q1'26: 8.93× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.76) × ERP
WACC = 82% × Ke + 18% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 7,432.30 Current price: 2,102.00
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
5 Rev. Ana.
5 EPS Ana. 		Dec 2027
5 Rev. Ana.
5 EPS Ana. 		Dec 2028
4 Rev. Ana.
4 EPS Ana. 		Dec 2029
3 Rev. Ana.
2 EPS Ana. 		Dec 2030
3 Rev. Ana.
2 EPS Ana.
Revenue
4.77B
est: 4.77B (+0.0%)
6.83B
est: 6.90B (-1.1%)
10.86B
est: 10.89B (-0.2%)
14.19B
est: 14.08B (+0.7%)
20.53B
est: 24.53B (-16.3%)
29.30B
est: 29.56B (-0.9%)
36.79B
est: 37.21B (-1.1%)
46.18B
44.87B – 47.43B
+24.1% YoY
55.17B
53.55B – 56.91B
+19.5% YoY
63.80B
63.42B – 64.18B
+15.6% YoY
75.57B
73.38B – 77.80B
+18.4% YoY
86.24B
83.74B – 88.78B
+14.1% YoY
EBITDA
-211.16M
est: 673.98M (-131.3%)
586.57M
est: 976.59M (-39.9%)
1.25B
est: 1.54B (-18.9%)
2.14B
est: 1.99B (+7.3%)
4.50B
est: 3.15B (+42.9%)
4.00B
est: 3.79B (+5.5%)
4.61B
est: 4.77B (-3.5%)
5.93B
5.76B – 6.09B
+24.1% YoY
7.08B
6.87B – 7.30B
+19.5% YoY
8.19B
8.14B – 8.24B
+15.6% YoY
9.70B
9.42B – 9.98B
+18.4% YoY
11.07B
10.75B – 11.39B
+14.1% YoY
EBIT
-309.15M
est: 485.08M (-163.7%)
432.78M
est: 702.88M (-38.4%)
783.59M
est: 1.11B (-29.3%)
1.54B
est: 1.43B (+7.2%)
3.81B
est: 2.47B (+54.2%)
2.33B
est: 2.98B (-21.9%)
2.15B
est: 3.75B (-42.7%)
4.66B
4.52B – 4.78B
+24.1% YoY
5.56B
5.40B – 5.74B
+19.5% YoY
6.43B
6.39B – 6.47B
+15.6% YoY
7.62B
7.40B – 7.84B
+18.4% YoY
8.69B
8.44B – 8.95B
+14.1% YoY
Net Income
-381.23M
est: -374.22M (-1.9%)
455.99M
est: 525.39M (-13.2%)
563.00M
est: 376.36M (+49.6%)
1.02B
est: 917.50M (+10.8%)
2.57B
est: 2.69B (-4.6%)
2.80B
est: 3.00B (-6.6%)
975.00M
est: 1.58B (-38.3%)
2.24B
1.83B – 2.57B
+41.5% YoY
3.29B
2.96B – 4.08B
+47.3% YoY
4.28B
4.26B – 5.66B
+29.8% YoY
5.19B
4.99B – 5.39B
+21.3% YoY
6.57B
6.32B – 6.82B
+26.7% YoY
SGA
3.07B
est: 2.69B (+14.0%)
4.20B
est: 3.89B (+7.9%)
6.08B
est: 6.14B (-1.0%)
8.24B
est: 7.94B (+3.7%)
10.72B
est: 13.63B (-21.3%)
15.91B
est: 16.42B (-3.1%)
21.04B
est: 20.67B (+1.8%)
25.65B
24.92B – 26.35B
+24.1% YoY
30.65B
29.74B – 31.61B
+19.5% YoY
35.44B
35.23B – 35.65B
+15.6% YoY
41.98B
40.76B – 43.22B
+18.4% YoY
47.90B
46.51B – 49.31B
+14.1% YoY
EPS
-14.87
est: -11.45 (-29.9%)
15.69
est: 16.08 (-2.4%)
17.79
est: 11.52 (+54.5%)
31.75
est: 28.08 (+13.1%)
79.52
est: 83.06 (-4.3%)
86.16
est: 93.64 (-8.0%)
30.60
est: 49.39 (-38.0%)
70.60
57.35 – 80.24
+43.0% YoY
109.60
92.60 – 127.36
+55.2% YoY
150.61
133.15 – 177.03
+37.4% YoY
162.10
155.99 – 168.31
+7.6% YoY
205.30
197.56 – 213.17
+26.7% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-13 B- 3/5 4/5 3/5 4/5 1/5 1/5 2/5
2026-05-12 B- 3/5 4/5 3/5 4/5 1/5 1/5 2/5
2026-05-11 B- 3/5 4/5 3/5 4/5 1/5 1/5 2/5
2026-05-08 B- 3/5 4/5 3/5 4/5 1/5 1/5 2/5
2026-05-07 B- 3/5 4/5 3/5 4/5 1/5 1/5 2/5
2026-05-01 B- 2/5 4/5 3/5 4/5 1/5 1/5 1/5
2026-04-30 B- 2/5 4/5 3/5 4/5 1/5 1/5 1/5
2026-04-28 B- 2/5 4/5 3/5 4/5 1/5 1/5 1/5
2026-04-27 B- 3/5 4/5 3/5 4/5 1/5 1/5 2/5
2026-04-24 B- 3/5 4/5 3/5 4/5 1/5 1/5 2/5
2026-04-23 B- 3/5 4/5 3/5 4/5 1/5 1/5 2/5
2026-04-22 B- 3/5 4/5 3/5 4/5 1/5 1/5 2/5
2026-04-21 B- 3/5 4/5 3/5 4/5 1/5 1/5 2/5
2026-04-20 B- 3/5 4/5 3/5 4/5 1/5 1/5 2/5
2026-04-17 B- 3/5 4/5 3/5 4/5 1/5 1/5 2/5
2026-04-16 B- 3/5 4/5 3/5 4/5 1/5 1/5 2/5
2026-04-15 B- 3/5 4/5 3/5 4/5 1/5 1/5 2/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
153.67M
OE per share TTM
4.70
Owner's Yield
0.21%
Maintenance CapEx ratio
10.14%
Maint CapEx / Avg PPE
1.8%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
1.45M
Shares Outstanding
30.90M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Daiki Okiyama Vice President and Head of Accounting & Tax and Finance Division — male
Hiromune Shishido Chief Technology Officer of Medical Platform Business & Vice President — male
Junzaburo Kiuchi Senior Vice President, GC and Head of Legal & Compliance Division — male
Kohei Takiguchi Chief Executive Officer, President & Director — male
Noriyoshi Owari Vice President & Head of Corporate Development and Finance Division — male
Ryo Kawahara Senior Vice President, Chief Financial Officer & Director — male
Ryusuke Inamoto Vice President, Chief Technology Officer of HR Platform Business & Deputy General Manager of HR Platform — male
Sakae Koyama Vice President & CFO of Medical Platform Division — male
Takeshi Muro Vice President & Head of Corporate Communications — male
Yosuke Ishizaki Senior Vice President & Head of HR Platform Business — male
Yutaka Tokimasa Senior Vice president & CHRO — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Healthcare Information Services